Navigation Links
BEN in Medical Technology

Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture

...onsumers make 160 million decisions to purchase Unilever products. In the United States, the portfolio includes major brand icons such as: Axe, ben & Jerry's, Bertolli, Breyers, Caress, Country Crock, Degree, Dove personal care products, Hellmann's, Klondike, Knorr, Lipton, Popsicle, Promise, ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

...ared to coronary artery bypass graft (CABG) surgery. Total medical costs at one year were also lower with PCI. Analysis of the data was presented by ben van Hout, Ph.D., of the University of Utrecht, The Netherlands, at the annual EuroPCR Scientific Program in Barcelona. "This analysis demonstrate...

Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline

...Ltd Tel: +44-1799-532920 Dr Edward E. Hodgkin, CEO enquiries@biotica.com Financial Dynamics Tel: +44(0)20-7831-3113 ben Atwell Ben.Atwell@fd.com ...

Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer

...SA: HUYA China: Shenzhen Chipscreen Biosciences, Ltd. Jan Tuttleman, PhD ben Ni, PhD Vice President, Head of Xian-Ping LU, PhD Marketing Therapeutics President and Chief HUYA Bio...

Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease

...e work could lead to the initial validation of amyloid as a therapeutic target of interest and potential biomarker for PD-related cognitive decline. ben Schmand, PhD, of Academic Medical Center (The Netherlands) has been funded to extend an observational clinical study begun three years ago. His study ...

Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients

...just one to five treatment sessions. The Promise of RapidArc Using Varian's RapidArc radiotherapy technology in the treatment of brain tumors, ben Slotman, who is professor and chairman of the Department of Radiation Oncology at the VU University Medical Center in Amsterdam, Netherlands, said he ...

Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients

...Immune cell function testing for the optimization of the therapeutic drug monitoring in selected heart transplant patients, a case series" (T. ben Gal, V. Yaari, M. Israeli, et al.) -- poster presentation, 5:45 p.m. - 6:45 p.m. (General Posters: Poster Session II) Friday, April 11 -- "Succ...

Researchers Use Magnetism to Target Cells to Animal Arteries

..., Ph.D., Ivan S. Alferiev, Ph.D., and Darryl Williams, of Children's Hospital; Boris Polyak, M.D., and Gary Friedman, Ph.D., of Drexel University; and ben Yellen, Ph.D., of Duke University. About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as t...

YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country

...ures Samuel L. Jackson, Omarion, Kat DeLuna, Mekhi Pfifer, Elisha Cuthbert, Maria Menounos, Shannon Elizabeth, comedian Russell Peters, Kelly Rowland, ben Jelen, DJ Rekha, State Radio, Shotgun Honeymoon, Emmy Rossum, and more in PSAs, school visits, and/or special events across the country. Beginning t...

CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

Novagali Pharma Announces Positive Vekacia Clinical Results From Pivotal Phase III Trial in Vernal Keratoconjunctivitis

...cular allergy throughout Europe and Mediterranean area and lead by Pr David ben Ezra, Hadassah Hebrew University Hospital, Jerusalem, who first reported on...ought significant benefits even in severe forms of the disease" declared Pr ben Ezra, study lead investigator "It can confidently be said that now, the tre...

Independent publication supports the profile of CeNeS phase II compound, CNS 5161

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension

...rate the benefits of combining a renin inhibitor with a diuretic during its pilot clinical development programme of SPP100 between 2000-2002 [5]. Mr ben Tan, Speedel Head of Business Development & Licensing commented "In the antihypertensive drug market, the most commonly prescribed fixed combinati...

FDA approves IND on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development an...
Other Tags
(Date:7/25/2014)... 25, 2014 Biometrics industry expands ... to digital technology for online & commerce payments while ... (NASDAQ: GOOG ), LifeLock Inc. (NYSE: ... ), Apple Inc. (NASDAQ: AAPL ) and ... NXTD) a biometric authentication company focused on the growing ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... native animal species for food or commercial food sale, ... in the decline of many species of primates and ... more than half of the species being consumed are ... surveying not only the meat made available for sale ... forest by hunters and brought to villages for consumption, ...
Breaking Biology News(10 mins):Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
(Date:7/25/2014)... genes are switched on or off plays a key ... metabolism, UT Southwestern Medical Center researchers have found., The ... obesity and diabetes, since the transcription factor involved ... influence the body,s sensitivity to insulin and leptin signaling. ... regulation of food intake and sugar disposal, and obesity ...
(Date:7/25/2014)... Innerspire, LLC ( http://www.innerspire.com ) announced ... a Creative Enrollment Specialist. In this role, Greg will ... well as his accomplished design skills to further develop ... to service the creative marketing needs of ... with small business owners and individuals looking to accelerate ...
(Date:7/25/2014)... 2014 The American Brain Tumor Association ... “ABTA CommYOUnity™” during its annual patient and family conference ... the brain tumor community as we – the first ... support services and funding brain tumor research – extend ... brain tumor awareness and getting our materials and services ...
(Date:7/25/2014)... 25, 2014 There are 700,000 people in ... each day. Though when someone hears the words, “you have ... unsure of the next step and where to turn. , ... out that next step by providing and pursuing the answers ... Brian Olson, member of the ABTA’s Board of Directors and ...
(Date:7/25/2014)... July 25, 2014 Progress in understanding ... a new era of promising brain tumor treatments, according ... School, director of the Center for Neuro-Oncology, Dana-Farber Cancer ... annual Patient and Family Conference in Chicago, July 25-26, ... and new technology are impacting the development of new ...
Breaking Medicine News(10 mins):Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2Health News:Innerspire, LLC Continues National Expansion 2Health News:Innerspire, LLC Continues National Expansion 3Health News:Innerspire, LLC Continues National Expansion 4Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 2Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 2Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 4
Other Contents